A Three-Dimensional Printed Polycaprolactone–Biphasic-Calcium-Phosphate Scaffold Combined with Adipose-Derived Stem Cells Cultured in Xenogeneic Serum-Free Media for the Treatment of Bone Defects
Source abstract
Abstract
The efficacy of a three-dimensional printed polycaprolactone–biphasic-calcium-phosphate scaffold (PCL–BCP TDP scaffold) seeded with adipose-derived stem cells (ADSCs), which were cultured in xenogeneic serum-free media (XSFM) to enhance bone formation, was assessed in vitro and in animal models. The ADSCs were isolated from the buccal fat tissue of six patients using enzymatic digestion and the plastic adherence method. The proliferation and osteogenic differentiation of the cells cultured in XSFM when seeded on the scaffolds were assessed and compared with those of cells cultured in a medium containing fetal bovine serum (FBS). The cell–scaffold constructs were cultured in XSFM and were implanted into calvarial defects in thirty-six Wistar rats to assess new bone regeneration. The proliferation and osteogenic differentiation of the cells in the XSFM medium were notably better than that of the cells in the FBS medium. However, the efficacy of the constructs in enhancing new bone formation in the calvarial defects of rats was not statistically different to that achieved using the scaffolds alone. In conclusion, the PCL–BCP TDP scaffolds were biocompatible and suitable for use as an osteoconductive framework. The XSFM medium could support the proliferation and differentiation of ADSCs in vitro. However, the cell–scaffold constructs had no benefit in the enhancement of new bone formation in animal models.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Mesenchymal stem cell research · Tissue Engineering and Regenerative Medicine · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Prince of Songkla University, Hatyai 90110, Thailand
Department of Molecular Biotechnology and Bioinformatics, Faculty of Science, Prince of Songkla University, Hatyai 90110, Thailand
Funding
Faculty of Dentistry, Prince of Songkla University
References (66)
Show source-provided references
1. Physical characteristics and biocompatibility of the polycaprolactone-biphasic calcium phosphate scaffolds fabricated using the modified melt stretching and multilayer deposition10.1177/0885328216633890 ↗
2. Effects of polycaprolactone-biphasic calcium phosphate scaffolds on enhancing growth and differentiation of osteoblasts
3. In vivo biocompatibility and degradation of novel Polycaprolactone-Biphasic Calcium phosphate scaffolds used as a bone substitute
4. Assessment of bone regeneration of a tissue-engineered bone complex using human dental pulp stem cells/poly(epsilon-caprolactone)-biphasic calcium phosphate scaffold constructs in rabbit calvarial defects10.1007/s10856-017-5883-x ↗
5. Biological characteristic effects of human dental pulp stem cells on poly-epsilon-caprolactone-biphasic calcium phosphate fabricated scaffolds using modified melt stretching and multilayer deposition10.1007/s10856-016-5833-z ↗
6. Rittipakorn, P., Thuaksuban, N., Mai-Ngam, K., Charoenla, S., and Noppakunmongkolchai, W. (2021). Bioactivity of a novel polycaprolactone-hydroxyapatite scaffold used as a carrier of low dose BMP-2: An in vitro study. Polymers, 13.10.3390/polym13030466 ↗
7. Polycaprolactone/hydroxyapatite composite scaffolds: Preparation, characterization, and in vitro and in vivo biological responses of human primary bone cells10.1002/jbm.a.32657 ↗
8. Darie-Nita, R.N., Rapa, M., and Frackowiak, S. (2022). Special features of polyester-based materials for medical applications. Polymers, 14.10.3390/polym14050951 ↗
9. Poly(epsilon-caprolactone) as a potential material for a temporary joint spacer10.1016/S0142-9612(02)00163-1 ↗
10. Scaffolds in tissue engineering bone and cartilage10.1016/S0142-9612(00)00121-6 ↗
11. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A review10.1016/j.actbio.2011.11.017 ↗
12. The association of human primary bone cells with biphasic calcium phosphate (betaTCP/HA 70:30) granules increases bone repair10.1007/s10856-011-4530-1 ↗
13. Angiogenic and osteogenic regeneration in rats via calcium phosphate scaffold and endothelial cell co-culture with human bone marrow mesenchymal stem cells (MSCs), human umbilical cord MSCs, human induced pluripotent stem cell-derived MSCs and human embryonic stem cell-derived MSCs10.1002/term.2395 ↗
14. Human periodontal ligament stem cells cultured onto cortico-cancellous scaffold drive bone regenerative process10.22203/eCM.v032a12 ↗
15. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: Case report10.1016/j.jcms.2004.06.002 ↗
16. Effect of expanded bone marrow-derived osteoprogenitor cells seeded into polycaprolactone/tricalcium phosphate scaffolds in new bone regeneration of rabbit mandibular defects10.1007/s10856-018-6030-z ↗
17. Repair of calvarial defects with customised tissue-engineered bone grafts II. Evaluation of cellular efficiency and efficacy in vivo10.1089/10763270360697030 ↗
18. Evaluation of a hybrid scaffold/cell construct in repair of high-load-bearing osteochondral defects in rabbits10.1016/j.biomaterials.2005.07.040 ↗
19. Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts10.1016/j.biomaterials.2006.09.032 ↗
20. Buccal fat pad, an oral access source of human adipose stem cells with potential for osteochondral tissue engineering: An in vitro study10.1089/ten.tec.2009.0487 ↗
21. Use of mesenchymal stem cells for therapy of cardiac disease10.1161/CIRCRESAHA.116.303614 ↗
22. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue10.1634/stemcells.2005-0342 ↗
23. Adipose tissue-derived stem cells as a therapeutic tool for cardiovascular disease10.4330/wjc.v7.i8.454 ↗
24. Human adipose tissue is a source of multipotent stem cells10.1091/mbc.e02-02-0105 ↗
25. Mesenchymal stem cells from Bichat’s fat pad: In vitro comparison with adipose-derived stem cells from subcutaneous tissue10.1089/biores.2012.0291 ↗
26. Porcine adipose-derived stem cells from buccal fat pad and subcutaneous adipose tissue for future preclinical studies in oral surgery10.1186/scrt359 ↗
27. Application of buccal fat pad-derived stem cells in combination with autogenous iliac bone graft in the treatment of maxillomandibular atrophy: A preliminary human study10.1016/j.ijom.2016.01.003 ↗
28. Serum-free media for the production of human mesenchymal stromal cells: A review10.1111/cpr.12063 ↗
29. Xeno-free strategies for safe human mesenchymal stem/stromal cell expansion: Supplements and coatings10.1155/2017/6597815 ↗
30. Defined serum-free media for in vitro expansion of adipose-derived mesenchymal stem cells10.1016/j.jcyt.2014.02.006 ↗
31. A novel serum-free medium for the expansion of human mesenchymal stem cells10.1186/scrt8 ↗
32. Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells10.5966/sctm.2012-0072 ↗
33. A xeno-free culture method that enhances Wharton’s jelly mesenchymal stromal cell culture efficiency over traditional animal serum-supplemented cultures10.1016/j.jcyt.2013.07.012 ↗
34. Evaluation of platelet lysate as a substitute for FBS in explant and enzymatic isolation methods of human umbilical cord MSCs10.1038/s41598-018-30772-4 ↗
35. Human mesenchymal stem cells from the umbilical cord matrix: Successful isolation and ex vivo expansion using serum-/xeno-free culture media10.1002/biot.201200340 ↗
36. Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton’s jelly derived mesenchymal stem cells? A comparative study10.1186/scrt477 ↗
37. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement10.1080/14653240600855905 ↗
38. Biodegradable polycaprolactone-chitosan three-dimensional scaffolds fabricated by melt stretching and multilayer deposition for bone tissue engineering: Assessment of the physical properties and cellular response10.1088/1748-6041/6/1/015009 ↗
39. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering10.1016/j.addr.2007.03.016 ↗
40. Osteoinductive biomaterials: Current knowledge of properties, experimental models and biological mechanisms10.22203/eCM.v021a31 ↗
41. The influence of nanostructured materials on biointerfacial interactions10.1016/j.addr.2012.06.001 ↗
42. Calcium phosphate-based osteoinductive materials10.1021/cr800427g ↗
43. Requirement of calcium and phosphate ions in expression of sodium-dependent vitamin C transporter 2 and osteopontin in MC3T3-E1 osteoblastic cells10.1016/S0167-4889(03)00065-X ↗
44. Mechanical versus enzymatic isolation of stromal vascular fraction cells from adipose tissue10.1186/s40064-015-1509-2 ↗
45. Adipose-derived stem cells: Comparison between two methods of isolation for clinical applications10.1016/j.amsu.2017.07.018 ↗
46. Allogeneic cell therapy: A new paradigm in therapeutics10.1161/CIRCRESAHA.114.305495 ↗
47. Concise review: Review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease10.5966/sctm.2015-0101 ↗
48. Human serum is as efficient as fetal bovine serum in supporting proliferation and differentiation of human multipotent stromal (mesenchymal) stem cells in vitro and in vivo10.1007/s12015-011-9274-2 ↗
49. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow10.1002/stem.139 ↗
50. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue10.1634/stemcells.2006-0627 ↗
51. Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: Potential feasibility for clinical applications10.3727/096368908785096024 ↗
52. Growth and proliferation of caprine bone marrow mesenchymal stem cells on different culture media10.1016/j.tice.2020.101446 ↗
53. Standardized xeno- and serum-free culture platform enables large-scale expansion of high-quality mesenchymal stem/stromal cells from perinatal and adult tissue sources10.1016/j.jcyt.2020.09.004 ↗
54. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)10.1016/j.jcyt.2013.02.006 ↗
55. The generation of adipocytes by the neural crest10.1242/dev.002642 ↗
56. Human dental pulp stem cells: From biology to clinical applications
57. Concise review: The surface markers and identity of human mesenchymal stem cells10.1002/stem.1681 ↗
58. Characterization of mesenchymal stem cells from human dental pulp, preapical follicle and periodontal ligament
59. Human dental pulp stem cells differentiate into neural crest-derived melanocytes and have label-retaining and sphere-forming abilities10.1089/scd.2008.0012 ↗
60. Age-related yield of adipose-derived stem cells bearing the low-affinity nerve growth factor receptor
61. Anti-L-NGFR and -CD34 monoclonal antibodies identify multipotent mesenchymal stem cells in human adipose tissue10.1089/scd.2009.0408 ↗
62. Influences of xeno-free media on mesenchymal stem cell expansion for clinical application10.1007/s13770-020-00306-z ↗
63. Diverse impact of xeno-free conditions on biological and regenerative properties of hUC-MSCs and their extracellular vesicles10.1007/s00109-016-1471-7 ↗
64. Effects of a defined xeno-free medium on the growth and neurotrophic and angiogenic properties of human adult stem cells10.1016/j.jcyt.2017.02.360 ↗
65. Optimization of the use of a pharmaceutical grade xeno-free medium for in vitro expansion of human mesenchymal stem/stromal cells10.1002/term.2588 ↗
66. Isolation, expansion and characterization of bone marrow-derived mesenchymal stromal cells in serum-free conditions10.1007/s00441-013-1783-7 ↗